| INTRODUCTION
Proteoglycans (PGs) are a class of extracellular matrix and surfaceassociated proteins involved in many physiological processes, such as signal transduction, cellular homeostasis, membrane integrity, corepressor activity, morphogen gradient formation, lipid catabolism and scaffolding. 1 PGs consist of a core protein, which is linked to glycosaminoglycan (GAG) disaccharide chains. Structurally, PGs are very diverse having different lengths and composition of disaccharides, with various types of modifications of phosphorylation, sulfation, and different combinations of core proteins. 2 Assembly of GAGs on the core protein results in different groups of sulfated PGs such as chondroitin sulfate (CSPGs), heparan sulfate (HSPGs) and modified form of CSPGs the dermatan sulfate (DSPGs). 3 Synthesis of a common tetrasaccharide linker chain is the initial step in heterogeneous CSPGs, HSPGs and DSPGs formation.
Xylosyltransferases (XylTs) catalyze the transfer of xylose to the core protein serine. Two enzymes XYLT1 (MIM 608124) and XYLT2
(MIM 608125) with XylT activity have been described to catalyze this reaction in humans. 4 Additional sugar residues are added by specific enzymes, including B4GALT7 (GalT-I), B3GALT6 (GalT-II) and B3GAT3 (GlcAT-1). A defect in any of these steps causes severe autosomal recessive disorders (MIM 604327, 615291, 606374).
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Spondyloocular syndrome (SOS; MIM 605822) is caused by biallelic sequence variants in the XYLT2 gene. 6 Here, we have reported the clinical follow-up of 2 families originally used to describe SOS. In addition, using whole exome sequencing (WES) we have identified 2 homozygous missense variants in the XYLT2 in the same 2 families.
| MATERIALS AND METHODS

| Study approval
This study was performed according to the declaration of Helsinki protocols and approved by Institutional Review Board (Technical University, Munich, Germany). Written informed consent for publication of images was obtained from all members.
| Research subjects
A consanguineous family A, of Iraqi origin, was clinically described previously by Schmidt et al 7 and Rudolph et al. 8 Similarly, family B, of Turkish origin, was described previously by Alanay et al. 9 
| Genetic analysis
In family A, genome-wide linkage analysis was performed using the Affymetrix 10K Mapping Array. The statistical analysis was carried out with Allegro. 10 Whole exome sequencing was performed in both the families (A and B) using HiSeq 2500 systems (Illumina, San Diego, California). 11 All the filtered variants were inserted into an in-house database. Subsequently, we queried the database to identify only rare homozygous variants, thus 2 homozygous variants were identified in the families, which were further validated by Sanger sequencing.
3 | RESULTS facial dysmorphism, short trunk, reduced lumbal lordosis, immobile spine with kyphosis, platyspondyly and mild osteoporosis was present in all 6 affected family members. In addition, they showed features of poor eyesight due to dense cataract, retinal degeneration/detachment, and consecutive phtisis bulbi.
| Clinical description
All 6 affected members underwent a follow-up examination 13 years after the family was reported 7, 8 ; however, molecular analysis was performed in 5 of these individuals. Their current age ranges between 27 and 37 years. They had normal weight (59-96 kg), height individual (II-6) had a heart murmur, while individual II-5 revealed a systolic heart murmur. A sonography of the kidney showed no abnormalities (Supporting information, Table S1 ).
As described previously by Alanay et al, 9 a single affected member in family B, had SOS-related phenotypic spectrum including bilateral cataract, generalized platyspondyly and osteoporosis, facial hypotonia, thin upper lip, ventricular septal defect and speaking difficulties. In addition, the affected member showed unique features including short stature, hyperextensible joints, hyperelastic skin and thoracic kyphosis. Follow-up examination for family B was not available.
| Linkage analysis
In family A, genome-wide linkage analysis was performed using Affy- ( Figure 1B) . Fine mapping using eleven microsatellite markers narrowed down the region to 6 cM between D17S931 and D17S788, with a maximum 3.27 LOD score obtained with marker D17S1868
( Figure 1D ).
| WES and Sanger sequencing
Using DNA of affected members of both the families (A and B), WES was performed at the Institute of Human Genetics, Helmholtz Alanay et al 9 Munns et al Zentrum Munich, Germany. 11 After following a step-by-step filtering process for screening homozygous variants, 2 potential homozygous missense variants were identified in the XYLT2 gene (NM_022167.3).
In family A, the missense variant (c.1159C > T, p.Arg387Trp) was located in exon 6, while in family B (c.2548G > C, p.Asp850His) it was located in exon 11 (Table S2 ). Both the variants affect highly conserved amino acid positions (Figure 2A -C) and were predicted pathogenic by in silico online tools such as PolyPhen-2, CADD, and SIFT. These variants were absent in different databases (ExAC, genomeAD, 1000 Genome) and 7000 in-house exomes. WES was followed by Sanger sequencing all available members of the families ( Figure 2C ,E).
| DISCUSSION
PGs play a key role in multiple cellular processes and represent a group of glycosylated macromolecules, mostly expressed on the cell surface and in the extracellular matrix. Since XylT 2 catalyzes the initiation of GAG assembly to the PG core protein serine, 12, 13 it is crucial to PG function. Any pathogenic mutation in core protein or in the GAGs chain modifying enzymes affects proliferation, ossification, and maturation of chondrocytes. 14,15 Therefore, it is certain that an addition of xylose to the serine residue at the core protein of PGs is the crucial first step in GAGs initiation, which is catalyzed by xylosyltransferase. 16 Two xylosyltransferases (XYLT1, XYLT2) are paralogs having a high homology in the catalytic domains. 13 Although, both XYLT1
and XYLT2 show no functional differences in vitro tissue-specific expression differences have been reported in soft tissues in humans 13, 16 and mice, 17 where deficiency in mice is associated with polycystic kidney disease.
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The clinical entity SOS was first described in 2 families of Iraqi and Turkish origin. 7,9 These 2 families were characterized at a genetic level in the present study. Recently, 2 groups have described SOS in seven other families of different ethnic backgrounds. 6, 18, 19 are highly conserved ( Figure 2C ) and might possibly affect secondary structure leading to non-functional XYLT2 protein.
In conclusion, we have reported 2 novel variants in the XYLT2 gene in the 2 families originally used to define the SOS syndrome.
This increases the mutation spectrum, signifying and supporting a greater role of XYLT2 in the pathogenesis of SOS. Furthermore, our finding will also help in determining proper genotype-phenotype correlation in patients suffering from XYLT2-related pathogenesis.
